EP3810807A4 - Methods and compositions for the analysis of cancer biomarkers - Google Patents

Methods and compositions for the analysis of cancer biomarkers Download PDF

Info

Publication number
EP3810807A4
EP3810807A4 EP18923183.0A EP18923183A EP3810807A4 EP 3810807 A4 EP3810807 A4 EP 3810807A4 EP 18923183 A EP18923183 A EP 18923183A EP 3810807 A4 EP3810807 A4 EP 3810807A4
Authority
EP
European Patent Office
Prior art keywords
compositions
analysis
methods
cancer biomarkers
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18923183.0A
Other languages
German (de)
French (fr)
Other versions
EP3810807A1 (en
Inventor
Brandon STEELMAN
Julia Meyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clear Gene Inc
Original Assignee
Clear Gene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clear Gene Inc filed Critical Clear Gene Inc
Publication of EP3810807A1 publication Critical patent/EP3810807A1/en
Publication of EP3810807A4 publication Critical patent/EP3810807A4/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
EP18923183.0A 2018-06-22 2018-06-22 Methods and compositions for the analysis of cancer biomarkers Pending EP3810807A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2018/039163 WO2019245587A1 (en) 2018-06-22 2018-06-22 Methods and compositions for the analysis of cancer biomarkers

Publications (2)

Publication Number Publication Date
EP3810807A1 EP3810807A1 (en) 2021-04-28
EP3810807A4 true EP3810807A4 (en) 2022-01-19

Family

ID=68984201

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18923183.0A Pending EP3810807A4 (en) 2018-06-22 2018-06-22 Methods and compositions for the analysis of cancer biomarkers

Country Status (4)

Country Link
EP (1) EP3810807A4 (en)
AU (1) AU2018428853A1 (en)
CA (1) CA3103572A1 (en)
WO (1) WO2019245587A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015195949A2 (en) 2014-06-18 2015-12-23 Clear Gene, Inc. Methods, compositions, and devices for rapid analysis of biological markers
US11401558B2 (en) 2015-12-18 2022-08-02 Clear Gene, Inc. Methods, compositions, kits and devices for rapid analysis of biological markers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017106790A1 (en) * 2015-12-18 2017-06-22 Clear Gene, Inc. Methods, compositions, kits and devices for rapid analysis of biological markers

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017106790A1 (en) * 2015-12-18 2017-06-22 Clear Gene, Inc. Methods, compositions, kits and devices for rapid analysis of biological markers

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BELLAHCÈNE A ET AL: "Expression of Bone Sialoprotein, a Bone Matrix Protein, in Human Breast Cancer'", CANCER RESEARCH, 1 June 1994 (1994-06-01), pages 2823 - 2826, XP055871912, Retrieved from the Internet <URL:https://cancerres.aacrjournals.org/content/54/11/2823> [retrieved on 20211212] *
GIUSSANI M ET AL: "Extracellular matrix proteins derived from the tumor microenvironment as circulating breast cancer diagnostic markers", EUROPEAN JOURNAL OF CANCER, vol. 61, 10 July 2016 (2016-07-10), XP029633975, ISSN: 0959-8049, DOI: 10.1016/S0959-8049(16)61137-1 *
See also references of WO2019245587A1 *

Also Published As

Publication number Publication date
WO2019245587A1 (en) 2019-12-26
AU2018428853A1 (en) 2021-01-14
EP3810807A1 (en) 2021-04-28
CA3103572A1 (en) 2019-12-26

Similar Documents

Publication Publication Date Title
EP3551185A4 (en) Compositions and methods for treating cdk4/6-mediated cancer
EP3707158A4 (en) Cancer biomarkers and methods of use thereof
EP3775877A4 (en) Cancer serum biomarkers and methods of use thereof
EP3894392A4 (en) Compositions and methods for the treatment of cancer
EP3612641A4 (en) Compositions and methods for library construction and sequence analysis
EP3824080A4 (en) Methods of analyzing cells
AU2019343184A1 (en) Compositions and methods for treating cancer with anti-CD123 immunotherapy
EP3773718A4 (en) Compositions and methods comprising anti-nrp2 antibodies
EP3775290A4 (en) Compositions and methods for cancer or neoplasia assessment
EP3863615A4 (en) Methods for the treatment of solid tumor cancers using illudins and biomarkers
EP3860452A4 (en) Analysis instrument
EP3594365A4 (en) Biomarker for her2-positive cancer and anti-her2 therapy and use thereof
EP3500262A4 (en) Compositions and methods for cancer immunotherapy
EP3946470A4 (en) Improved methods and compositions for synthetic biomarkers
EP3253891A4 (en) Compositions and methods for determining endometrial cancer prognosis
EP3698144A4 (en) Compositions, methods and kits for diagnosis of lung cancer
EP3927838A4 (en) Methods and compositions for early cancer detection
EP3786305A4 (en) Biomarker for depression and use thereof
EP3962953A4 (en) Cancer associated antibody compositions and methods of use
EP3880232A4 (en) Methods and compositions for cancer immunotherapy
EP3893901A4 (en) Compositions and methods for immunotherapies
EP3752194A4 (en) Compositions and methods for tumor immunotherapy
EP3773585A4 (en) Compositions and methods for treating cancer
EP3740590A4 (en) Kits and methods for diagnosing lung cancer
EP3717502A4 (en) Compositions and methods for characterizing cancer

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201216

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20211220

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/6876 20180101ALI20211214BHEP

Ipc: C12Q 1/6883 20180101ALI20211214BHEP

Ipc: C12Q 1/6886 20180101AFI20211214BHEP

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230511